Skip to content

Clinical trials

Hemorrhage trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Country / region: Belgium Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20092
20122
20133
20146
20152
20171
20184
20191
20204
20211
20223
20234
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting6
Unknown status4
Withdrawn2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Antonius Hospital4
Ethicon, Inc.3
AstraZeneca2
Boehringer Ingelheim2
Idorsia Pharmaceuticals Ltd.2
Universitaire Ziekenhuizen KU Leuven2
University Hospital, Ghent2
3-D Matrix Europe SAS1
Alexion Pharmaceuticals, Inc.1
ArtVentive Medical Group, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage37
Stroke6
Thrombosis6
Embolism and Thrombosis5
Atrial Fibrillation4
Myocardial Infarction4
Aortic Valve Stenosis3
Cardiovascular Diseases3
Emergencies3
Gastrointestinal Hemorrhage3

Trials

Showing 51 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.